| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adjuvant bevacizumab-containing therapy in triple-negative breast cancer (BEATRICE): primary results of a randomised, phase 3 trial
|
Cameron, David
|
|
2013
|
14 |
10 |
p. 933-942
10 p.
|
artikel
|
| 2 |
Adjuvant bevacizumab: positive data from a negative trial
|
Perez-Garcia, Jose
|
|
2013
|
14 |
10 |
p. 910-911
2 p.
|
artikel
|
| 3 |
Androgen deprivation associated with acute kidney injury
|
Granovetter, Michael
|
|
2013
|
14 |
10 |
p. e392-
1 p.
|
artikel
|
| 4 |
A new biomarker for graft-versus-host disease
|
Burki, Talha Khan
|
|
2013
|
14 |
10 |
p. e395-
1 p.
|
artikel
|
| 5 |
Aurora kinases in head and neck cancer
|
Mehra, Ranee
|
|
2013
|
14 |
10 |
p. e425-e435
nvt p.
|
artikel
|
| 6 |
BEACOPPescalated versus ABVD in advanced Hodgkin's lymphoma
|
André, Marc
|
|
2013
|
14 |
10 |
p. 911-912
2 p.
|
artikel
|
| 7 |
Breast cancer in Arab populations: molecular characteristics and disease management implications
|
Chouchane, Lotfi
|
|
2013
|
14 |
10 |
p. e417-e424
nvt p.
|
artikel
|
| 8 |
Challenges relating to solid tumour brain metastases in clinical trials, part 2: neurocognitive, neurological, and quality-of-life outcomes. A report from the RANO group
|
Lin, Nancy U
|
|
2013
|
14 |
10 |
p. e407-e416
nvt p.
|
artikel
|
| 9 |
Challenges relating to solid tumour brain metastases in clinical trials, part 1: patient population, response, and progression. A report from the RANO group
|
Lin, Nancy U
|
|
2013
|
14 |
10 |
p. e396-e406
nvt p.
|
artikel
|
| 10 |
Chernobyl Exclusion Zone: a very strange place
|
Brierley, Bente Brattland
|
|
2013
|
14 |
10 |
p. 932-
1 p.
|
artikel
|
| 11 |
Combination endocrine treatments unproven in breast cancer
|
Buzdar, Aman U
|
|
2013
|
14 |
10 |
p. 917-918
2 p.
|
artikel
|
| 12 |
Controversy in treatment of advanced ovarian cancer
|
Scambia, Giovanni
|
|
2013
|
14 |
10 |
p. 920-921
2 p.
|
artikel
|
| 13 |
Correction to Lancet Oncol 2013; 14: 989
|
|
|
2013
|
14 |
10 |
p. e391-
1 p.
|
artikel
|
| 14 |
Correction to Lancet Oncol 2013; 14: 790
|
|
|
2013
|
14 |
10 |
p. e391-
1 p.
|
artikel
|
| 15 |
Early intervention for smoldering multiple myeloma
|
Sharma, Sharan Prakash
|
|
2013
|
14 |
10 |
p. e393-
1 p.
|
artikel
|
| 16 |
Effect of initial treatment strategy on survival of patients with advanced-stage Hodgkin's lymphoma: a systematic review and network meta-analysis
|
Skoetz, Nicole
|
|
2013
|
14 |
10 |
p. 943-952
10 p.
|
artikel
|
| 17 |
EGFR inhibitors for wild-type EGFR NSCLC: to use or not to use?
|
Jassem, Jacek
|
|
2013
|
14 |
10 |
p. 916-917
2 p.
|
artikel
|
| 18 |
Erlotinib versus docetaxel as second-line treatment of patients with advanced non-small-cell lung cancer and wild-type EGFR tumours (TAILOR): a randomised controlled trial
|
Garassino, Marina Chiara
|
|
2013
|
14 |
10 |
p. 981-988
8 p.
|
artikel
|
| 19 |
Fulvestrant plus anastrozole or placebo versus exemestane alone after progression on non-steroidal aromatase inhibitors in postmenopausal patients with hormone-receptor-positive locally advanced or metastatic breast cancer (SoFEA): a composite, multicentre, phase 3 randomised trial
|
Johnston, Stephen RD
|
|
2013
|
14 |
10 |
p. 989-998
10 p.
|
artikel
|
| 20 |
Hospital contact for mental disorders in survivors of childhood cancer and their siblings in Denmark: a population-based cohort study
|
Lund, Lasse Wegener
|
|
2013
|
14 |
10 |
p. 971-980
10 p.
|
artikel
|
| 21 |
Icotinib: kick-starting the Chinese anticancer drug industry
|
Camidge, D Ross
|
|
2013
|
14 |
10 |
p. 913-914
2 p.
|
artikel
|
| 22 |
Icotinib versus gefitinib in previously treated advanced non-small-cell lung cancer (ICOGEN): a randomised, double-blind phase 3 non-inferiority trial
|
Shi, Yuankai
|
|
2013
|
14 |
10 |
p. 953-961
9 p.
|
artikel
|
| 23 |
Intelligent knife shown to be effective in surgery
|
Granovetter, Michael
|
|
2013
|
14 |
10 |
p. e392-
1 p.
|
artikel
|
| 24 |
Ipilimumab for metastatic uveal melanoma
|
Gilbert, Judith A
|
|
2013
|
14 |
10 |
p. e394-
1 p.
|
artikel
|
| 25 |
I WANT YOU: Propaganda at The British Library
|
Coburn, Cassie
|
|
2013
|
14 |
10 |
p. 931-
1 p.
|
artikel
|
| 26 |
Keeping patients front and centre in the era of negative results
|
The Lancet Oncology,
|
|
2013
|
14 |
10 |
p. 909-
1 p.
|
artikel
|
| 27 |
Long-term results of dose-dense paclitaxel and carboplatin versus conventional paclitaxel and carboplatin for treatment of advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer (JGOG 3016): a randomised, controlled, open-label trial
|
Katsumata, Noriyuki
|
|
2013
|
14 |
10 |
p. 1020-1026
7 p.
|
artikel
|
| 28 |
Lung cancer screening approved in the USA
|
Cleghorn, Sean
|
|
2013
|
14 |
10 |
p. e394-
1 p.
|
artikel
|
| 29 |
Milk thistle: early seeds of potential
|
Siegel, Abby B
|
|
2013
|
14 |
10 |
p. 929-930
2 p.
|
artikel
|
| 30 |
MOGA 2013 Annual Scientific Meeting
|
Collingridge, David
|
|
2013
|
14 |
10 |
p. 928-
1 p.
|
artikel
|
| 31 |
Preference for subcutaneous or intravenous administration of trastuzumab in patients with HER2-positive early breast cancer (PrefHer): an open-label randomised study
|
Pivot, Xavier
|
|
2013
|
14 |
10 |
p. 962-970
9 p.
|
artikel
|
| 32 |
PrefHer: finally addressing the preferences of her, too
|
Melichar, Bohuslav
|
|
2013
|
14 |
10 |
p. 914-915
2 p.
|
artikel
|
| 33 |
Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trial
|
Kreissman, Susan G
|
|
2013
|
14 |
10 |
p. 999-1008
10 p.
|
artikel
|
| 34 |
Reforms in the English National Health Service: delivery of cancer services by clinical commissioning groups
|
Thomas, Helen
|
|
2013
|
14 |
10 |
p. 921-923
3 p.
|
artikel
|
| 35 |
Reforms in the English National Health Service: the role of the general practitioner
|
Buckman, Laurence
|
|
2013
|
14 |
10 |
p. 923-925
3 p.
|
artikel
|
| 36 |
Reforms in the English National Health Service: the voluntary sector in cancer care provision
|
Krell, Jonathan
|
|
2013
|
14 |
10 |
p. 925-926
2 p.
|
artikel
|
| 37 |
Righting a long-standing wrong for Henrietta Lacks
|
Burki, Talha Khan
|
|
2013
|
14 |
10 |
p. e395-
1 p.
|
artikel
|
| 38 |
Role of purging in PBSC transplantation for neuroblastoma
|
Klingebiel, Thomas
|
|
2013
|
14 |
10 |
p. 919-
1 p.
|
artikel
|
| 39 |
Sex hormones and risk of breast cancer in premenopausal women: a collaborative reanalysis of individual participant data from seven prospective studies
|
|
|
2013
|
14 |
10 |
p. 1009-1019
11 p.
|
artikel
|
| 40 |
Surgery or radiotherapy for early-stage lung cancer—a potential comparison bias
|
Van Schil, Paul E
|
|
2013
|
14 |
10 |
p. e390-
1 p.
|
artikel
|
| 41 |
The end of the Liverpool Care Pathway?
|
Sykes, Nigel
|
|
2013
|
14 |
10 |
p. 926-927
2 p.
|
artikel
|
| 42 |
The ZOOM trial: more boon than doom?
|
Hutton, Brian
|
|
2013
|
14 |
10 |
p. e387-e388
nvt p.
|
artikel
|
| 43 |
Tomosynthesis cuts recall rates for breast cancer screening
|
Tanday, Sanjay
|
|
2013
|
14 |
10 |
p. e393-
1 p.
|
artikel
|
| 44 |
Unexpected Lessons in Love
|
Cantor, Abi
|
|
2013
|
14 |
10 |
p. 930-931
2 p.
|
artikel
|
| 45 |
What can we learn from the ZOOM trial?
|
Hayoz, Stefanie
|
|
2013
|
14 |
10 |
p. e388-
1 p.
|
artikel
|
| 46 |
What can we learn from the ZOOM trial? – Authors' reply
|
Amadori, Dino
|
|
2013
|
14 |
10 |
p. e388-e390
nvt p.
|
artikel
|
Tijdschrift beschrijving